bioAffinity Technologies Inc. (BIAF) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    bioAffinity Technologies ...

    NASDAQ: BIAF · Real-Time Price · USD
    0.29
    0.01 (2.04%)
    At close: Jun 09, 2025, 3:59 PM

    bioAffinity Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 9.36M 2.53M 4.8K n/a
    Cost of Revenue
    		 5.98M 1.74M 467.00 4.82K
    Gross Profit
    		 3.38M 791.62K 4.34K -4.82K
    Operating Income
    		 -8.95M -7.97M -4.01M -2.21M
    Interest Income
    		 17.61K 122.13K 46.71K 424.00
    Pretax Income
    		 -9.03M -7.92M -8.15M -6.32M
    Net Income
    		 -9.04M -7.94M -8.15M -6.33M
    Selling & General & Admin
    		 9.94M 6.79M 2.73M 880.77K
    Research & Development
    		 1.78M 1.72M 1.29M 1.33M
    Other Expenses
    		 605.64K 249.59K -1.87M 724.93K
    Operating Expenses
    		 12.33M 8.76M 4.02M 2.21M
    Interest Expense
    		 92.47K 37.13K 2.53M 1M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 18.32M 10.51M 4.02M 2.21M
    Income Tax Expense
    		 11.65K 20.99K 2.46K 1.95K
    Shares Outstanding (Basic)
    		 12.13M 8.75M 4.5M 7.38M
    Shares Outstanding (Diluted)
    		 12.13M 8.75M 4.5M 7.38M
    EPS (Basic)
    		 -0.73 -0.91 -1.81 -0.86
    EPS (Diluted)
    		 -0.73 -0.91 -1.81 -0.86
    EBITDA
    		 -8.33M -7.63M -5.61M -2.2M
    EBIT
    		 -8.94M -7.88M -5.62M -2.21M
    Depreciation & Amortization
    		 605.64K 249.59K 10.18K 4.82K

    Add to Watchlist